Skip to main content
Glama

query_drug_risk

Read-onlyIdempotent

Fetch human-reviewed drug-specific clinical-risk signals for a project, including biomarker quality, Phase 1 ORR flag-only data, provenance, extractor versions, and pending-review counts. Use this before interpreting engine 2.6.0 drug-specific multipliers or flags.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
project_idYesUUID of the project whose reviewed drug-specific clinical-risk signals should be queried.

Output Schema

TableJSON Schema
NameRequiredDescriptionDefault
dataYesDrug-specific clinical-risk substrate for a project. Returns reviewed signals only; pending rows are counted but excluded from scoring.

Schema Changelog

Changes observed during successful MCP inspections.

  1. Added

TDQS

A4.2/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and non-destructive behavior. The description adds useful context beyond this: it characterizes the data as human-reviewed, includes 'Phase 1 ORR flag-only data', provenance, extractor versions, and pending-review counts, and clarifies the relationship to engine 2.6.0. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences, front-loaded with the primary purpose and data contents, followed by a concise usage directive. Every sentence adds value; no filler or redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The tool has a single parameter and an output schema, so much of the return structure is externally documented. The description covers the tool's role, data composition, and nuance about 'Phase 1 ORR flag-only data'. It lacks explicit details on pagination or authorization, but these are not critical given the schema and read-only annotations.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, with a clear description for project_id. The tool description adds no additional parameter-level semantics beyond what the schema already provides, so the baseline of 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with a specific verb ('Fetch') and clearly identifies the resource ('human-reviewed drug-specific clinical-risk signals for a project'), then enumerates the included data elements. This unambiguously distinguishes it from sibling tools like query_benchmarks or get_evidence.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states when to use the tool: 'Use this before interpreting engine 2.6.0 drug-specific multipliers or flags.' This provides clear context, though it doesn't enumerate alternatives or when-not-to-use scenarios.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources